| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.5016 | 43 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.2027 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.7351 | 36 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.1762 | 52 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.2826 | 33 |
| GSM780721 | Untreated after 4 days (C3_2) | 61.1641 | 65 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.2299 | 52 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 54.4656 | 59 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.2181 | 58 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.0991 | 52 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.998 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.3242 | 46 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.2887 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.9578 | 37 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.4641 | 29 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.7219 | 44 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.3739 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.4546 | 47 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.1374 | 49 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.7663 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 54.3858 | 59 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.0764 | 49 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 55.654 | 60 |